HERACLIS_BLV_D: Increasing Response Rates During 2‐Year Bulevirtide Real‐Life Therapy in Chronic Hepatitis D

BLV monotherapy is safe and effective for the treatment of CHD patients followed at Greek tertiary liver centres offering increasing rates of VRHDV RNA undetectability and BR or combined response exceeding 90%, 80% and 70%, respectively, at 2 years of therapy.

Authors

Institutions

Publication Details

Journal
Liver International
Published
2025-06-16
DOI
https://doi.org/10.1111/liv.70151
Citations
2
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
2.71

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HERACLIS_BLV_D: Increasing Response Rates During 2‐Year Bulevirtide Real‐Life Therapy in Chronic Hepatitis D

Christos Triantos, George Ν. Dalekos, Eleni Gigi, Ioannis Goulis et al.
2 citations
Liver International
Hepatitis B Virus Studies
2.71
article

HERACLIS_BLV_D: Increasing Response Rates During 2‐Year Bulevirtide Real‐Life Therapy in Chronic Hepatitis D

Christos Triantos, George Ν. Dalekos, Eleni Gigi, Ioannis Goulis, Spilios Manolakopoulos, Θεόδωρος Ανδρουτσάκος, Dimitrios Christodoulou, Paraskevi Fytili, Iliana Mani, C. Veretanos, George Papatheodoridis, Emmanouil Koullias, Dimitrios S. Karagiannakis, Nikolaos Papadopoulos, Melanie Deutsch, Emmanouil Sinakos, Athanasios Kontos, Alkistis Papatheodoridi, Spyridon Pantzios, Ioannis Elefsiniotis, Maria Mela, Εvangelos Cholongitas, Jiannis Vlachogiannakos, Hariklia Kranidioti, Kalliopi Zachou, George Giannoulis, Μargarita Papatheodoridi, Spyridon Michopoulos, John Koskinas, Konstantinos Mimidis, Αlexandra Alexopoulou, Nikolaos Psychos, Evdoxia Avramopoulou, Vasilios Papadimitropoulos, Dimitrios Dimitroulopoulos, Vasilios Sevastianos, Larisa Vasilieva, Dimitrios Lymperopoulos
article en
2 citations

Abstract

BLV monotherapy is safe and effective for the treatment of CHD patients followed at Greek tertiary liver centres offering increasing rates of VRHDV RNA undetectability and BR or combined response exceeding 90%, 80% and 70%, respectively, at 2 years of therapy.

Liver InternationalVol. 45(7)
National and Kapodistrian University of Athens (GR), Aristotle University of Thessaloniki (GR), General University Hospital of Patras (GR), 401 General Military Hospital of Athens (GR), University Hospital of Larissa (GR), Alexandra Hospital (GR), Laiko General Hospital of Athens (GR), Hospital Agioi Anargyroi (GR), St Savas Hospital (GR), University Hospital of Ioannina (GR), University Hospital of Alexandroupolis (GR), Evangelismos Hospital (GR)
Gilead Sciences
Openalex Percentile: Top 10%
Hepatitis B Virus Studies
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.